Long COVID is keeping people out of work for months
Prolonged, and often severe, symptoms from the disease often sideline workers for months after they get sick.
Watch CBS News
Prolonged, and often severe, symptoms from the disease often sideline workers for months after they get sick.
The program is using free Narcan vending machines to help save lives and give people treatment options.
On Jan. 23, 2020, Wuhan, the capital of the central province of Hubei, with a population of more than 12 million, became the first city in the world to adopt measures to cut off the transmission of the then-unidentified virus.
Many people said they didn't seek treatment last year for serious conditions or illnesses, according to Gallup.
The latest government figures show a sharp decline in U.S. fertility in recent years.
The decline was not accompanied by a rise in exemptions, the CDC says, suggesting many children could still catch up on their shots.
It's the second time in just a few months that products made by the same drugmaker have been linked to dozens of child deaths.
Gas stoves are linked to health problems such as asthma — but a regulator who floated a ban met severe pushback.
The department says the recommendation comes after the holiday season resulted in increased travel and indoor gatherings amid COVID-19, flu, RSV and other viruses spreading in the United States.
January is Cervical Cancer Awareness Month, and the Michigan Department of Health and Human Services is encouraging Michigan residents to get regularly screened for cancer.
Pivotal results on a variety of next generation approaches are expected soon, as a panel of FDA advisers is set to weigh the future of immunization against SARS-CoV-2.
Since the recall was first issued in 2019, about 70 more fatalities have been reported. This number includes eight fatalities that happened after the original recall announcement.
The longstanding practice of "watchful waiting," or delaying treatment to see whether children and teens outgrow or overcome obesity, "doesn't work," a leading researcher says.
The researchers found "a staggering" 90% of people living with long COVID only had a mild illness to start — but people who were hospitalized were more likely to develop the lasting symptoms.
Leqembi, from Japan's Eisai and its U.S. partner Biogen, is a rare success in a field accustomed to failed experimental treatments for the incurable condition.